Dorsey & Whitney Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.7M Sell
31,172
-661
-2% -$670K 1.58% 9
2025
Q4
$34.2M Sell
31,833
-4,020
-11% -$3.84M 1.81% 9
2025
Q3
$27.4M Sell
35,853
-12,088
-25% -$9M 1.44% 12
2025
Q2
$37.4M Sell
47,941
-760
-2% -$591K 1.98% 9
2025
Q1
$40.2M Sell
48,701
-901
-2% -$750K 2.32% 5
2024
Q4
$38.3M Buy
49,602
+7,562
+18% +$6.26M 2.11% 6
2024
Q3
$37.2M Buy
42,040
+8,860
+27% +$7.97M 1.98% 5
2024
Q2
$30M Sell
33,180
-1,353
-4% -$1.08M 2.08% 8
2024
Q1
$26.9M Sell
34,533
-1,961
-5% -$1.4M 1.83% 8
2023
Q4
$21.3M Sell
36,494
-1,641
-4% -$958K 1.63% 9
2023
Q3
$20.5M Sell
38,135
-1,104
-3% -$569K 1.78% 7
2023
Q2
$18.4M Buy
39,239
+793
+2% +$333K 1.52% 8
2023
Q1
$13.2M Buy
38,446
+630
+2% +$212K 1.2% 15
2022
Q4
$13.8M Sell
37,816
-1,209
-3% -$429K 1.35% 12
2022
Q3
$12.6M Sell
39,025
-2,224
-5% -$705K 1.32% 13
2022
Q2
$13.4M Sell
41,249
-2,153
-5% -$646K 1.36% 12
2022
Q1
$12.4M Buy
43,402
+192
+0.4% +$49.4K 1.09% 21
2021
Q4
$11.9M Buy
43,210
+46
+0.1% +$11.7K 1% 25
2021
Q3
$9.97M Sell
43,164
-1,854
-4% -$458K 0.92% 28
2021
Q2
$10.3M Sell
45,018
-1,851
-4% -$372K 0.98% 28
2021
Q1
$8.76M Sell
46,869
-2,384
-5% -$466K 0.87% 28
2020
Q4
$8.32M Buy
49,253
+322
+0.7% +$48.1K 0.97% 26
2020
Q3
$7.24M Sell
48,931
-351
-0.7% -$54.3K 0.97% 28
2020
Q2
$8.09M Sell
49,282
-1,662
-3% -$255K 1.13% 22
2020
Q1
$7.07M Sell
50,944
-782
-2% -$107K 1.19% 20
2019
Q4
$6.8M Buy
51,726
+1,402
+3% +$163K 0.91% 28
2019
Q3
$5.63M Buy
50,324
+2,960
+6% +$330K 0.83% 31
2019
Q2
$5.25M Buy
47,364
+119
+0.3% +$14K 0.81% 37
2019
Q1
$6.13M Sell
47,245
-4,402
-9% -$535K 0.96% 27
2018
Q4
$5.98M Sell
51,647
-498
-1% -$55.6K 1.06% 22
2018
Q3
$5.59M Buy
52,145
+2,403
+5% +$240K 0.87% 34
2018
Q2
$4.25M Buy
49,742
+861
+2% +$70.7K 0.74% 41
2018
Q1
$3.78M Sell
48,881
-330
-0.7% -$26.6K 0.7% 41
2017
Q4
$4.16M Buy
49,211
+2,212
+5% +$188K 0.77% 42
2017
Q3
$4.02M Buy
46,999
+8,773
+23% +$720K 0.8% 40
2017
Q2
$3.15M Buy
38,226
+4,160
+12% +$339K 0.63% 45
2017
Q1
$2.87M Buy
34,066
+13,750
+68% +$1.1M 0.58% 49
2016
Q4
$1.49M Sell
20,316
-403
-2% -$30K 0.34% 72
2016
Q3
$1.66M Sell
20,719
-1,030
-5% -$82.4K 0.38% 66
2016
Q2
$1.71M Buy
21,749
+1,460
+7% +$110K 0.39% 63
2016
Q1
$1.46M Sell
20,289
-290
-1% -$21.9K 0.37% 66
2015
Q4
$1.73M Buy
20,579
+239
+1% +$19.8K 0.46% 58
2015
Q3
$1.7M Sell
20,340
-671
-3% -$56.6K 0.48% 56
2015
Q2
$1.75M Sell
21,011
-639
-3% -$48.7K 0.45% 58
2015
Q1
$1.57M Buy
21,650
+181
+0.8% +$12.9K 0.4% 66
2014
Q4
$1.48M Sell
21,469
-328
-2% -$22.1K 0.38% 67
2014
Q3
$1.41M Sell
21,797
-300
-1% -$19K 0.38% 64
2014
Q2
$1.37M Sell
22,097
-259
-1% -$15.5K 0.3% 63
2014
Q1
$1.32M Sell
22,356
-898
-4% -$50.1K 0.3% 64
2013
Q4
$1.19M Buy
23,254
+1,309
+6% +$65.5K 0.32% 68
2013
Q3
$1.1M Buy
21,945
+3,045
+16% +$159K 0.33% 67
2013
Q2
$929K Buy
+18,900
New +$1.03M 0.31% 65

Other funds holding LLY

Dorsey & Whitney Trust's LLY Position: Q1 2026 in Review

Dorsey & Whitney Trust reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $670K and leaving 31,172 shares worth $28.7M. The position accounts for 1.58% of the portfolio, ranked #9.

Dorsey & Whitney Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.2M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dorsey & Whitney Trust held 31,172 shares of Eli Lilly worth $28.7M as of Q1 2026.
  • Dorsey & Whitney Trust sold 661 Eli Lilly shares in Q1 2026, an estimated $670K.
  • Eli Lilly made up 1.58% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #9 holding.
  • Dorsey & Whitney Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Dorsey & Whitney Trust's Eli Lilly position peaked at $40.2M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.